Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
(Thomson Reuters ONE) -
BB Biotech AG /
Director's Dealings announcement according to §15a WpHG (the German Securities
Trading Act)
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
--------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement
--------------------------------------------------------------------------------
Name: Strein, Klaus
Professional role: Person with executive functions: Member of
administrative or supervisory body
--------------------------------------------------------------------------------
Designation of the financial instrument
--------------------------------------------------------------------------------
ISIN: CH0038389992
Designation: Registered share BB Biotech AG
--------------------------------------------------------------------------------
Details of the transaction
--------------------------------------------------------------------------------
Type of transaction: Buy
Date: 04.02.2016
Place (stock exchange): Swiss Stock Exchange
Price: 229.463
Currency: CHF
Quantity: 2600
Business volume: 596603.80
--------------------------------------------------------------------------------
Details of the company with the publishing obligation:
--------------------------------------------------------------------------------
Issuer:
BB Biotech AG
Schwertstrasse 6
CH-8200 Schaffhausen
Switzerland
ISIN: CH0038389992
WKN: 888509
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BB Biotech AG via GlobeNewswire
[HUG#1984183]
Unternehmensinformation / Kurzprofil:
Datum: 05.02.2016 - 17:37 Uhr
Sprache: Deutsch
News-ID 449031
Anzahl Zeichen: 2557
contact information:
Town:
Schaffhausen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 284 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)"
steht unter der journalistisch-redaktionellen Verantwortung von
BB Biotech AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
